Tiziana Life Sciences – Demerger of StemPrintER September 17, 2020 – Posted in: Tiziana Life Sciences (TILS)

16/09/2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Demerger of StemPrintER and Distribution in Specie Proposed capital reduction and notice of General Meeting Tiziana Life Sciences Plc (LSE: TILS, NASDAQ: TLSA) a biotechnology company focussed on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that, following a strategic review of its clinical trial programs and core focus, it intends to demerge its StemPrintER and SPARE genomics-based personalised medicine business into a separate…

Continue reading